Acarix AB (publ) (ACARIX.ST)
Stockholm · SEK · Healthcare · Medical Devices
SEK 0.1846 (-1.07%) as of
Key statistics
- Market cap
- 229.00M
- EPS (TTM)
- -0.0400
- Dividend yield
- 0.00%
- 52-week range
- 0.1800 – 0.3445
- Beta
- -0.17
- Revenue (TTM)
- 9.22M
- Profit margin
- 0.00%
- Analyst target
- SEK 0.40
- Volume
- 1.43M
About Acarix AB (publ)
Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to support clinical decision making at the point of care. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Austria, Mauritius, and the United States. The company was founded in 2009 and is headquartered in Malmö, Sweden.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Malmö, Sweden
- Employees
- 8
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.